Literature DB >> 34617968

Anticoagulant Therapy in Patients Hospitalized With COVID-19.

Lana Wahid1, Thomas L Ortel2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34617968     DOI： 10.1001/jamainternmed.2021.6212

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Clinical features of thrombosis and bleeding in COVID-19.

Authors:  Mari R Thomas; Marie Scully
Journal:  Blood       Date:  2022-07-21       Impact factor: 25.476

Review 2.  Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.

Authors:  Chengyue Wang; Chengyuan Yu; Haijiao Jing; Xiaoming Wu; Valerie A Novakovic; Rujuan Xie; Jialan Shi
Journal:  Front Cell Infect Microbiol       Date:  2022-04-05       Impact factor: 6.073

3.  Clinical Characteristics of Hospitalized COVID-19 Patients Who Have Gastrointestinal Bleeds Requiring Intervention: A Case-Control Study.

Authors:  Ahmad Abulawi; Ali Al-Tarbsheh; Annie Leamon; Paul Feustel; Amit Chopra; Asra Batool
Journal:  Cureus       Date:  2022-07-03

Review 4.  Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Innocent G Asiimwe; Sudeep P Pushpakom; Richard M Turner; Ruwanthi Kolamunnage-Dona; Andrea L Jorgensen; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2022-04-25       Impact factor: 3.716
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.